Robeco Institutional Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Robeco Institutional Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,624	Closed	-$362K	–	1094
2023 Q1	$362K	Buy	+2,624	New	+$340K	﹤0.01%	877
2021 Q2	–	Sell	-2,041	Closed	-$152K	–	981
2021 Q1	$152K	Hold	2,041	–	–	﹤0.01%	892
2020 Q4	$348K	Sell	2,041 -1,374	-40%	-$204K	﹤0.01%	814
2020 Q3	$479K	Sell	3,415 -6,890	-67%	-$1.05M	﹤0.01%	763
2020 Q2	$1.65M	Buy	+10,305	New	+$1.4M	0.01%	686

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Robeco Institutional Asset Management's SRPT Position: Q2 2023 in Review

Robeco Institutional Asset Management sold out of Sarepta Therapeutics (SRPT) in Q2 2023, closing a stake of 2,624 shares — an estimated $362K sold.

Robeco Institutional Asset Management first reported a position in SRPT in Q2 2020 and held it in 5 quarters. The position peaked at $1.65M in Q2 2020. 405 funds tracked by Wall St. Rank hold SRPT as of Q2 2023.

Robeco Institutional Asset Management reported no remaining Sarepta Therapeutics position as of Q2 2023 after selling out during the quarter.
Robeco Institutional Asset Management sold 2,624 Sarepta Therapeutics shares in Q2 2023, an estimated $362K.
Robeco Institutional Asset Management first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 5 quarters.
Robeco Institutional Asset Management's Sarepta Therapeutics position peaked at $1.65M in Q2 2020.
405 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2023, filed 24 Jul 2023.